Skip to main content
OpenTrials

Clinical trial condition

Type I Diabetes

Explore clinical trials studying Type I Diabetes. Study availability and eligibility vary by location and protocol.

17 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Type I Diabetes trial results

Recruiting

Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)

NCT06739811

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • Hôpital Saint André -Centre Hospitalier Universitaire de Bordeaux Bordeaux, France
  • Centre Hospitalier Sud Francilien Corbeil-Essonnes, France
  • CHU Lille - Hôpital Huriez Lille, France
  • Centre Hospitalier Universitaire De Montpellier Montpellier, France
View Trial Details
Recruiting

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

NCT06964087

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • University of Alabama at Birmingham - Department of Medicina Birmingham, Alabama, United States
  • Diablo Clinical Research Center Walnut Creek, California, United States
  • Barbara Davis Center - University of Colorado Anschuttz Medical Campus Aurora, Colorado, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details
Completed

A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041

NCT04279613

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • Children's Hospital of Orange County Orange, California, United States
  • University of California - San Francisco San Francisco, California, United States
  • Stanford University Stanford, California, United States
  • Barbara Davis Center at University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
View all 16 locations
View Trial Details
Completed

A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes

NCT01928329

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Barbara Davis Center Aurora, Colorado, United States
  • Yale University New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
View Trial Details

Related conditions